Tegavivint (BC2059)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tegavivint (BC2059), covering 2025-07-04 to 2025-07-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]